Type 2 diabetes mellitus
Related entities
Findings (50)
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementHigher lactation intensity at 6-9 weeks postpartum was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, wi
Effect: improvement; HR 0.46; CI: 95% CI 0.29-0.71
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82
None
improvementLonger duration of lactation was independently associated with lower 2-year incidence of type 2 diabetes after gestational diabetes pregnancy in a graded dose-response manner, with >10 months of breas
Effect: improvement; HR 0.43; CI: 95% CI 0.22-0.82